Cellular processing of a multibranched lysine core with tumor antigen peptides and presentation of peptide epitopes recognized by cytotoxic T lymphocytes on antigen-presenting cells

Seisuke Ota, Toshiro Ono, Akimichi Morita, Akiko Uenaka, Mine Harada, Eiichi Nakayama

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

We showed that pRL1a multiple antigen peptide (MAP)-sensitized dendritic cell (DC) and P815 cell lysis by pRL1a-specific B-24 CTL was blocked by incubating target cells at 4°C during sensitization. The finding suggested that pRL1a MAP was mostly internalized in DC and P815 cells and produced pRL1a peptide epitopes for presentation with H-2Ld. Furthermore, we showed that sensitization with pRL1a MAP was inhibited by the addition of chloroquine, cycloheximide, and brefeldin A to the culture, but not by the addition of inhibitors for lysosomal proteases or proteasome. Inhibition of sensitization by the addition of chloroquine to the culture suggested the requirement of acidification of the endosomal compartment for pRL1a MAP processing. Inhibition of sensitization by the addition of cycloheximide and brefeldin A to the culture indicated the requirement of newly generated MHC class I antigen molecules and the involvement of transport of the peptide MHC class I complex from the endoplasmic reticulum to the Golgi. The findings suggested that pRL1a MAP in the endosomal compartment leaked to the cytosol, and degraded, and the pRL1a peptide produced was presented by the MHC class I pathway.

Original languageEnglish
Pages (from-to)1471-1476
Number of pages6
JournalCancer Research
Volume62
Issue number5
Publication statusPublished - Mar 1 2002

Fingerprint

Antigen Presentation
Cytotoxic T-Lymphocytes
Neoplasm Antigens
Antigen-Presenting Cells
Lysine
Epitopes
Peptides
Brefeldin A
Antigens
Chloroquine
Cycloheximide
Dendritic Cells
Histocompatibility Antigens Class I
Proteasome Inhibitors
Protease Inhibitors
Endoplasmic Reticulum
Cytosol

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Cellular processing of a multibranched lysine core with tumor antigen peptides and presentation of peptide epitopes recognized by cytotoxic T lymphocytes on antigen-presenting cells. / Ota, Seisuke; Ono, Toshiro; Morita, Akimichi; Uenaka, Akiko; Harada, Mine; Nakayama, Eiichi.

In: Cancer Research, Vol. 62, No. 5, 01.03.2002, p. 1471-1476.

Research output: Contribution to journalArticle

Ota, Seisuke ; Ono, Toshiro ; Morita, Akimichi ; Uenaka, Akiko ; Harada, Mine ; Nakayama, Eiichi. / Cellular processing of a multibranched lysine core with tumor antigen peptides and presentation of peptide epitopes recognized by cytotoxic T lymphocytes on antigen-presenting cells. In: Cancer Research. 2002 ; Vol. 62, No. 5. pp. 1471-1476.
@article{1021858271104eb5b887a6e51a8455b9,
title = "Cellular processing of a multibranched lysine core with tumor antigen peptides and presentation of peptide epitopes recognized by cytotoxic T lymphocytes on antigen-presenting cells",
abstract = "We showed that pRL1a multiple antigen peptide (MAP)-sensitized dendritic cell (DC) and P815 cell lysis by pRL1a-specific B-24 CTL was blocked by incubating target cells at 4°C during sensitization. The finding suggested that pRL1a MAP was mostly internalized in DC and P815 cells and produced pRL1a peptide epitopes for presentation with H-2Ld. Furthermore, we showed that sensitization with pRL1a MAP was inhibited by the addition of chloroquine, cycloheximide, and brefeldin A to the culture, but not by the addition of inhibitors for lysosomal proteases or proteasome. Inhibition of sensitization by the addition of chloroquine to the culture suggested the requirement of acidification of the endosomal compartment for pRL1a MAP processing. Inhibition of sensitization by the addition of cycloheximide and brefeldin A to the culture indicated the requirement of newly generated MHC class I antigen molecules and the involvement of transport of the peptide MHC class I complex from the endoplasmic reticulum to the Golgi. The findings suggested that pRL1a MAP in the endosomal compartment leaked to the cytosol, and degraded, and the pRL1a peptide produced was presented by the MHC class I pathway.",
author = "Seisuke Ota and Toshiro Ono and Akimichi Morita and Akiko Uenaka and Mine Harada and Eiichi Nakayama",
year = "2002",
month = "3",
day = "1",
language = "English",
volume = "62",
pages = "1471--1476",
journal = "Journal of Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "5",

}

TY - JOUR

T1 - Cellular processing of a multibranched lysine core with tumor antigen peptides and presentation of peptide epitopes recognized by cytotoxic T lymphocytes on antigen-presenting cells

AU - Ota, Seisuke

AU - Ono, Toshiro

AU - Morita, Akimichi

AU - Uenaka, Akiko

AU - Harada, Mine

AU - Nakayama, Eiichi

PY - 2002/3/1

Y1 - 2002/3/1

N2 - We showed that pRL1a multiple antigen peptide (MAP)-sensitized dendritic cell (DC) and P815 cell lysis by pRL1a-specific B-24 CTL was blocked by incubating target cells at 4°C during sensitization. The finding suggested that pRL1a MAP was mostly internalized in DC and P815 cells and produced pRL1a peptide epitopes for presentation with H-2Ld. Furthermore, we showed that sensitization with pRL1a MAP was inhibited by the addition of chloroquine, cycloheximide, and brefeldin A to the culture, but not by the addition of inhibitors for lysosomal proteases or proteasome. Inhibition of sensitization by the addition of chloroquine to the culture suggested the requirement of acidification of the endosomal compartment for pRL1a MAP processing. Inhibition of sensitization by the addition of cycloheximide and brefeldin A to the culture indicated the requirement of newly generated MHC class I antigen molecules and the involvement of transport of the peptide MHC class I complex from the endoplasmic reticulum to the Golgi. The findings suggested that pRL1a MAP in the endosomal compartment leaked to the cytosol, and degraded, and the pRL1a peptide produced was presented by the MHC class I pathway.

AB - We showed that pRL1a multiple antigen peptide (MAP)-sensitized dendritic cell (DC) and P815 cell lysis by pRL1a-specific B-24 CTL was blocked by incubating target cells at 4°C during sensitization. The finding suggested that pRL1a MAP was mostly internalized in DC and P815 cells and produced pRL1a peptide epitopes for presentation with H-2Ld. Furthermore, we showed that sensitization with pRL1a MAP was inhibited by the addition of chloroquine, cycloheximide, and brefeldin A to the culture, but not by the addition of inhibitors for lysosomal proteases or proteasome. Inhibition of sensitization by the addition of chloroquine to the culture suggested the requirement of acidification of the endosomal compartment for pRL1a MAP processing. Inhibition of sensitization by the addition of cycloheximide and brefeldin A to the culture indicated the requirement of newly generated MHC class I antigen molecules and the involvement of transport of the peptide MHC class I complex from the endoplasmic reticulum to the Golgi. The findings suggested that pRL1a MAP in the endosomal compartment leaked to the cytosol, and degraded, and the pRL1a peptide produced was presented by the MHC class I pathway.

UR - http://www.scopus.com/inward/record.url?scp=0036494627&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036494627&partnerID=8YFLogxK

M3 - Article

C2 - 11888922

AN - SCOPUS:0036494627

VL - 62

SP - 1471

EP - 1476

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0008-5472

IS - 5

ER -